AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
ACYCLOVIR USP
5 registrations across 3 African markets— 4 active
Markets with ACYCLOVIR USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| Alovir 400 Tablets Tablet Uncoated | 🇿🇲Zambia | Hetero Labs Limited | active | Dec 2030 |
| Zovinex Powder For Injection | 🇰🇪Kenya | NOVO Medi Sciences Pvt. Ltd. | active | Feb 2029 |
| APOVIR 400 Tablet | 🇰🇪Kenya | NATIONAL PHARMACY LTD | active | Jun 2028 |
| VIRHIR-400 Tablet | 🇰🇪Kenya | HIRAL LABS LIMITED | active | Apr 2028 |
| ACIVIR-200-DT 200MG DISPERSIBLE TABLET DISPERSIBLE TABLET | 🇲🇼Malawi | — | expired | Jun 2012 |
ACYCLOVIR USP in Africa — Regulatory Overview
ACYCLOVIR USP is registered across 3 African markets with 5 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Malawi, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 5 registrations, 4 (80%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.